A growing body of evidence shows that G-protein coupled receptors (GPR) play central roles in neuronal control of body functions, including psychiatric and metabolic disorders, and therefore present as targets for drug intervention for either [1]–[4]. The gene discussed is ALDH18A1; the disease is Other metabolic disease.